

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.92047324 |
| 2 | protoporphyrinogen IX metabolic process (GO:0046501) | 9.81836433 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 9.01731226 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.89378619 |
| 5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.72436174 |
| 6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.42215108 |
| 7 | heme biosynthetic process (GO:0006783) | 7.20398990 |
| 8 | tetrapyrrole biosynthetic process (GO:0033014) | 6.69544737 |
| 9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.16782344 |
| 10 | porphyrin-containing compound metabolic process (GO:0006778) | 6.11155026 |
| 11 | fructose metabolic process (GO:0006000) | 5.97149407 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 5.91238473 |
| 13 | heme metabolic process (GO:0042168) | 5.88575383 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.75971788 |
| 15 | lipoprotein transport (GO:0042953) | 5.67372750 |
| 16 | regulation of bile acid biosynthetic process (GO:0070857) | 5.46201829 |
| 17 | diacylglycerol metabolic process (GO:0046339) | 5.29765698 |
| 18 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.05381492 |
| 19 | endocrine process (GO:0050886) | 5.05381492 |
| 20 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.05381492 |
| 21 | regulation of cGMP biosynthetic process (GO:0030826) | 4.91996829 |
| 22 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.76418729 |
| 23 | regulation of systemic arterial blood pressure (GO:0003073) | 4.70308156 |
| 24 | erythrocyte maturation (GO:0043249) | 4.64155951 |
| 25 | hormone catabolic process (GO:0042447) | 4.62789849 |
| 26 | drug metabolic process (GO:0017144) | 4.59710953 |
| 27 | lysine metabolic process (GO:0006553) | 4.55612049 |
| 28 | lysine catabolic process (GO:0006554) | 4.55612049 |
| 29 | proline biosynthetic process (GO:0006561) | 4.32287865 |
| 30 | regulation of cellular extravasation (GO:0002691) | 4.31191647 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.30444129 |
| 32 | vitamin transmembrane transport (GO:0035461) | 4.28441774 |
| 33 | nucleoside diphosphate biosynthetic process (GO:0009133) | 4.26020793 |
| 34 | renal system process involved in regulation of blood volume (GO:0001977) | 4.25345014 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.23741459 |
| 36 | tetrapyrrole metabolic process (GO:0033013) | 4.23668352 |
| 37 | hemoglobin metabolic process (GO:0020027) | 4.16440420 |
| 38 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.13165556 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 4.12223322 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.06881696 |
| 41 | uronic acid metabolic process (GO:0006063) | 4.06881696 |
| 42 | cellular glucuronidation (GO:0052695) | 4.04400696 |
| 43 | positive regulation of pseudopodium assembly (GO:0031274) | 4.02612015 |
| 44 | GDP-mannose metabolic process (GO:0019673) | 3.98517985 |
| 45 | regulation of cGMP metabolic process (GO:0030823) | 3.97684667 |
| 46 | antibacterial humoral response (GO:0019731) | 3.97641843 |
| 47 | adhesion of symbiont to host cell (GO:0044650) | 3.95933191 |
| 48 | virion attachment to host cell (GO:0019062) | 3.95933191 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.94963760 |
| 50 | peptide hormone processing (GO:0016486) | 3.91788779 |
| 51 | proline metabolic process (GO:0006560) | 3.86014990 |
| 52 | antimicrobial humoral response (GO:0019730) | 3.85437973 |
| 53 | peptide catabolic process (GO:0043171) | 3.82158361 |
| 54 | vitamin A metabolic process (GO:0006776) | 3.81927922 |
| 55 | glycosphingolipid catabolic process (GO:0046479) | 3.80155869 |
| 56 | regulation of vitamin metabolic process (GO:0030656) | 3.78859715 |
| 57 | glycolipid catabolic process (GO:0019377) | 3.76921186 |
| 58 | protein-lipid complex assembly (GO:0065005) | 3.75544378 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.72238342 |
| 60 | tricarboxylic acid cycle (GO:0006099) | 3.71214330 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67953887 |
| 62 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.67831694 |
| 63 | cellular response to nitric oxide (GO:0071732) | 3.65390165 |
| 64 | erythrocyte development (GO:0048821) | 3.63685556 |
| 65 | digestion (GO:0007586) | 3.61886677 |
| 66 | cysteine metabolic process (GO:0006534) | 3.61869180 |
| 67 | carnitine metabolic process (GO:0009437) | 3.58932836 |
| 68 | adhesion of symbiont to host (GO:0044406) | 3.58583397 |
| 69 | regulation of pseudopodium assembly (GO:0031272) | 3.58541238 |
| 70 | positive regulation of respiratory burst (GO:0060267) | 3.52600005 |
| 71 | vitamin transport (GO:0051180) | 3.52118093 |
| 72 | cGMP-mediated signaling (GO:0019934) | 3.51143100 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49960621 |
| 74 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.45060333 |
| 75 | arginine metabolic process (GO:0006525) | 3.44755043 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.44209030 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 3.40667319 |
| 78 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.35348542 |
| 79 | triglyceride biosynthetic process (GO:0019432) | 3.35267462 |
| 80 | intestinal cholesterol absorption (GO:0030299) | 3.33137405 |
| 81 | response to methylmercury (GO:0051597) | 3.32023818 |
| 82 | glyoxylate metabolic process (GO:0046487) | 3.31404827 |
| 83 | heme transport (GO:0015886) | 3.30288325 |
| 84 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.29809008 |
| 85 | vitamin biosynthetic process (GO:0009110) | 3.28766230 |
| 86 | NADH metabolic process (GO:0006734) | 3.27729205 |
| 87 | sulfate transmembrane transport (GO:1902358) | 3.27719926 |
| 88 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.27230692 |
| 89 | regulation of cholesterol metabolic process (GO:0090181) | 3.26506054 |
| 90 | phospholipid efflux (GO:0033700) | 3.26097491 |
| 91 | lipoprotein metabolic process (GO:0042157) | 3.25564932 |
| 92 | glycerol metabolic process (GO:0006071) | 3.23636221 |
| 93 | pigment biosynthetic process (GO:0046148) | 3.22213876 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.22195260 |
| 95 | intestinal absorption (GO:0050892) | 3.22063211 |
| 96 | glutathione biosynthetic process (GO:0006750) | 3.21860062 |
| 97 | quinone biosynthetic process (GO:1901663) | 3.21640274 |
| 98 | response to nitric oxide (GO:0071731) | 3.21279608 |
| 99 | transcytosis (GO:0045056) | 3.20617285 |
| 100 | acylglycerol biosynthetic process (GO:0046463) | 3.18744953 |
| 101 | neutral lipid biosynthetic process (GO:0046460) | 3.18744953 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.18699509 |
| 103 | fat-soluble vitamin metabolic process (GO:0006775) | 3.17843080 |
| 104 | carnitine shuttle (GO:0006853) | 3.17297395 |
| 105 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17149615 |
| 106 | sulfur amino acid catabolic process (GO:0000098) | 3.16659310 |
| 107 | digestive system process (GO:0022600) | 3.16099837 |
| 108 | ethanol oxidation (GO:0006069) | 3.12793301 |
| 109 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.12753402 |
| 110 | fatty acid oxidation (GO:0019395) | 3.12614657 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.12120118 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.11133152 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.11133152 |
| 114 | alkaloid metabolic process (GO:0009820) | 3.10142802 |
| 115 | sarcomere organization (GO:0045214) | 3.09865121 |
| 116 | drug catabolic process (GO:0042737) | 3.07931821 |
| 117 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.07637909 |
| 118 | midgut development (GO:0007494) | 3.07617677 |
| 119 | drinking behavior (GO:0042756) | 3.07325762 |
| 120 | bile acid metabolic process (GO:0008206) | 3.07297946 |
| 121 | response to lead ion (GO:0010288) | 3.06654541 |
| 122 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.06401471 |
| 123 | kynurenine metabolic process (GO:0070189) | 3.06240598 |
| 124 | sphingolipid catabolic process (GO:0030149) | 3.06043743 |
| 125 | ceramide catabolic process (GO:0046514) | 3.05407381 |
| 126 | lipid oxidation (GO:0034440) | 3.04437275 |
| 127 | fatty acid transmembrane transport (GO:1902001) | 3.04384589 |
| 128 | homocysteine metabolic process (GO:0050667) | 3.03565615 |
| 129 | fatty acid catabolic process (GO:0009062) | 3.00674384 |
| 130 | regulation of cholesterol esterification (GO:0010872) | 2.99147369 |
| 131 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96610367 |
| 132 | L-phenylalanine metabolic process (GO:0006558) | 2.96610367 |
| 133 | plasma lipoprotein particle organization (GO:0071827) | 2.96047241 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 2.95527249 |
| 135 | pigment metabolic process (GO:0042440) | 2.94161562 |
| 136 | high-density lipoprotein particle remodeling (GO:0034375) | 2.93643672 |
| 137 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.91964312 |
| 138 | carnitine transmembrane transport (GO:1902603) | 2.91111095 |
| 139 | alpha-linolenic acid metabolic process (GO:0036109) | 2.91003363 |
| 140 | cofactor biosynthetic process (GO:0051188) | 2.90253481 |
| 141 | carnitine transport (GO:0015879) | 2.88334799 |
| 142 | amino-acid betaine transport (GO:0015838) | 2.88334799 |
| 143 | valine metabolic process (GO:0006573) | 2.86952897 |
| 144 | oxidative phosphorylation (GO:0006119) | 2.84624512 |
| 145 | protein-lipid complex subunit organization (GO:0071825) | 2.82245021 |
| 146 | oxaloacetate metabolic process (GO:0006107) | 2.81745483 |
| 147 | response to arsenic-containing substance (GO:0046685) | 2.81129476 |
| 148 | erythrocyte differentiation (GO:0030218) | 2.77467124 |
| 149 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.75580366 |
| 150 | L-phenylalanine catabolic process (GO:0006559) | 2.75580366 |
| 151 | protein-lipid complex remodeling (GO:0034368) | 2.74291006 |
| 152 | macromolecular complex remodeling (GO:0034367) | 2.74291006 |
| 153 | plasma lipoprotein particle remodeling (GO:0034369) | 2.74291006 |
| 154 | negative regulation of sterol transport (GO:0032372) | 2.73048012 |
| 155 | negative regulation of cholesterol transport (GO:0032375) | 2.73048012 |
| 156 | short-chain fatty acid metabolic process (GO:0046459) | 2.68841385 |
| 157 | negative regulation of viral entry into host cell (GO:0046597) | 2.68320124 |
| 158 | reverse cholesterol transport (GO:0043691) | 2.67373573 |
| 159 | ethanol metabolic process (GO:0006067) | 2.67073330 |
| 160 | phospholipid homeostasis (GO:0055091) | 2.67043856 |
| 161 | aromatic amino acid family catabolic process (GO:0009074) | 2.66776377 |
| 162 | drug transmembrane transport (GO:0006855) | 2.66697485 |
| 163 | regulation of cholesterol homeostasis (GO:2000188) | 2.66688769 |
| 164 | urea cycle (GO:0000050) | 2.66502373 |
| 165 | urea metabolic process (GO:0019627) | 2.66502373 |
| 166 | cellular ketone body metabolic process (GO:0046950) | 2.66473475 |
| 167 | cholesterol homeostasis (GO:0042632) | 2.66318777 |
| 168 | cholesterol efflux (GO:0033344) | 2.65236468 |
| 169 | tryptophan catabolic process (GO:0006569) | 2.64907202 |
| 170 | indole-containing compound catabolic process (GO:0042436) | 2.64907202 |
| 171 | indolalkylamine catabolic process (GO:0046218) | 2.64907202 |
| 172 | monocarboxylic acid catabolic process (GO:0072329) | 2.63817019 |
| 173 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.63458163 |
| 174 | acetyl-CoA metabolic process (GO:0006084) | 2.62369734 |
| 175 | plasma lipoprotein particle clearance (GO:0034381) | 2.61333023 |
| 176 | bile acid and bile salt transport (GO:0015721) | 2.60450857 |
| 177 | myeloid cell development (GO:0061515) | 2.60401456 |
| 178 | sterol homeostasis (GO:0055092) | 2.59675756 |
| 179 | purine nucleotide salvage (GO:0032261) | 2.57787779 |
| 180 | response to nitrosative stress (GO:0051409) | 2.55933183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.28567916 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.12061926 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.06892076 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.01520702 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.77256241 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.44335444 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.41171426 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12270380 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87085165 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.57153358 |
| 11 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.54187999 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50310808 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48481034 |
| 14 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.45161384 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36416472 |
| 16 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.12245106 |
| 17 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.07327893 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03269162 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.99204166 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96978430 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96590085 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91545100 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90864286 |
| 24 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.80367880 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80155938 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77988629 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76138747 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74755461 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73502044 |
| 30 | SA1_27219007_Chip-Seq_Bcells_Human | 1.72760499 |
| 31 | GATA2_19941826_ChIP-Seq_K562_Human | 1.71578539 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.69813862 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67370719 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67031592 |
| 35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.66637254 |
| 36 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.64383949 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63473245 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62898181 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61247957 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58575763 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.57677305 |
| 42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54987686 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49077349 |
| 44 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48353089 |
| 45 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.47063681 |
| 46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.46622508 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.44755286 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43667937 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41392433 |
| 50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40976518 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40242515 |
| 52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40220661 |
| 53 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.39575117 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39554555 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.38538240 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.35428962 |
| 57 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.35262962 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35138991 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34440701 |
| 60 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34227469 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33014743 |
| 62 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.32725018 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31642365 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30937365 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30781778 |
| 66 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.30269115 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29857858 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.29707335 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29350488 |
| 70 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27574458 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24826932 |
| 72 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.24404533 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23182697 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21813583 |
| 75 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.19986676 |
| 76 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19295683 |
| 77 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18885425 |
| 78 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18112104 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16139555 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16074616 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15989549 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15362625 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15170789 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14926386 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14721514 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14033064 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13710499 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13238215 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12495772 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12246741 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11896575 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10622397 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10034815 |
| 94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09987131 |
| 95 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09683797 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09617015 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08045961 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07326107 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07185191 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07082176 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07035070 |
| 102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06685665 |
| 103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05685808 |
| 104 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.05545305 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05116842 |
| 106 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05014231 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04514934 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04288030 |
| 109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02917510 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02636813 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02604926 |
| 112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02384945 |
| 113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02320073 |
| 114 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02012681 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01792044 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01316445 |
| 117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01078190 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01064429 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00772354 |
| 120 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00535520 |
| 121 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00167766 |
| 122 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00077357 |
| 123 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99767469 |
| 124 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99682527 |
| 125 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98198097 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96937072 |
| 127 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96766173 |
| 128 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96762236 |
| 129 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96656234 |
| 130 | P300_27268052_Chip-Seq_Bcells_Human | 0.96538353 |
| 131 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96037829 |
| 132 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95713972 |
| 133 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.95615235 |
| 134 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95263096 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94874625 |
| 136 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93461580 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92964247 |
| 138 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92459993 |
| 139 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91883212 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91735624 |
| 141 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.91586500 |
| 142 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.90094472 |
| 143 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89224389 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 0.87929413 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87143413 |
| 146 | MAF_26560356_Chip-Seq_TH2_Human | 0.87094941 |
| 147 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.86923711 |
| 148 | MYB_26560356_Chip-Seq_TH1_Human | 0.86630295 |
| 149 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.85852853 |
| 150 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.85471797 |
| 151 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85465444 |
| 152 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84313988 |
| 153 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84136327 |
| 154 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83150363 |
| 155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83000922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 5.79872752 |
| 2 | MP0004147_increased_porphyrin_level | 5.44537286 |
| 3 | MP0005360_urolithiasis | 4.74967917 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.13598478 |
| 5 | MP0009379_abnormal_foot_pigmentation | 4.03014033 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.61253663 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.25230560 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.24943168 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.96211437 |
| 10 | MP0005365_abnormal_bile_salt | 2.72161532 |
| 11 | MP0009840_abnormal_foam_cell | 2.65281194 |
| 12 | MP0005083_abnormal_biliary_tract | 2.44712517 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.41767409 |
| 14 | MP0005409_darkened_coat_color | 2.40112652 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.40008167 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.28678858 |
| 17 | MP0003646_muscle_fatigue | 2.26452492 |
| 18 | MP0001664_abnormal_digestion | 2.13904752 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.10208156 |
| 20 | MP0003252_abnormal_bile_duct | 2.06843845 |
| 21 | MP0001188_hyperpigmentation | 2.02947293 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.97963970 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.91245967 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.84156469 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.83001293 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.78066845 |
| 27 | MP0004043_abnormal_pH_regulation | 1.68864458 |
| 28 | MP0005330_cardiomyopathy | 1.61467880 |
| 29 | MP0000609_abnormal_liver_physiology | 1.58437407 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.55454016 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.54018050 |
| 32 | MP0000749_muscle_degeneration | 1.53807528 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.52485223 |
| 34 | MP0005636_abnormal_mineral_homeostasis | 1.52308863 |
| 35 | MP0003718_maternal_effect | 1.47657083 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.44884522 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.44884522 |
| 38 | MP0003186_abnormal_redox_activity | 1.44297677 |
| 39 | MP0005332_abnormal_amino_acid | 1.42113016 |
| 40 | MP0003879_abnormal_hair_cell | 1.39373798 |
| 41 | MP0004858_abnormal_nervous_system | 1.37651430 |
| 42 | MP0002822_catalepsy | 1.33644745 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.33356292 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.31196413 |
| 45 | MP0004130_abnormal_muscle_cell | 1.31155052 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.30241584 |
| 47 | MP0000490_abnormal_crypts_of | 1.29542689 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.28373024 |
| 49 | MP0000751_myopathy | 1.26475253 |
| 50 | MP0000685_abnormal_immune_system | 1.24437879 |
| 51 | MP0002796_impaired_skin_barrier | 1.24228479 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.23317233 |
| 53 | MP0004036_abnormal_muscle_relaxation | 1.21866280 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.21177886 |
| 55 | MP0005166_decreased_susceptibility_to | 1.20440691 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.19113152 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17995141 |
| 58 | MP0000462_abnormal_digestive_system | 1.16951953 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.15417986 |
| 60 | MP0001544_abnormal_cardiovascular_syste | 1.14943782 |
| 61 | MP0005385_cardiovascular_system_phenoty | 1.14943782 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11648743 |
| 63 | MP0010630_abnormal_cardiac_muscle | 1.10554259 |
| 64 | MP0002136_abnormal_kidney_physiology | 1.09687488 |
| 65 | MP0001764_abnormal_homeostasis | 1.09226964 |
| 66 | MP0006054_spinal_hemorrhage | 1.09131146 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.09013563 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.08190057 |
| 69 | MP0002972_abnormal_cardiac_muscle | 1.07612584 |
| 70 | MP0000537_abnormal_urethra_morphology | 1.07434906 |
| 71 | MP0005501_abnormal_skin_physiology | 1.05170963 |
| 72 | MP0005535_abnormal_body_temperature | 1.04962611 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.04922317 |
| 74 | MP0004087_abnormal_muscle_fiber | 1.04524248 |
| 75 | MP0001756_abnormal_urination | 1.02363698 |
| 76 | MP0000598_abnormal_liver_morphology | 1.01982219 |
| 77 | MP0005266_abnormal_metabolism | 1.01834912 |
| 78 | MP0003866_abnormal_defecation | 1.01733415 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.01522771 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.98371580 |
| 81 | MP0009764_decreased_sensitivity_to | 0.96977119 |
| 82 | MP0008469_abnormal_protein_level | 0.96502434 |
| 83 | MP0005448_abnormal_energy_balance | 0.96358723 |
| 84 | MP0002269_muscular_atrophy | 0.96168506 |
| 85 | MP0000566_synostosis | 0.95282607 |
| 86 | MP0005381_digestive/alimentary_phenotyp | 0.94637525 |
| 87 | MP0009785_altered_susceptibility_to | 0.94554342 |
| 88 | MP0004270_analgesia | 0.94255516 |
| 89 | MP0001873_stomach_inflammation | 0.92918304 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.91171651 |
| 91 | MP0005025_abnormal_response_to | 0.90938968 |
| 92 | MP0009763_increased_sensitivity_to | 0.90654087 |
| 93 | MP0002098_abnormal_vibrissa_morphology | 0.90481840 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.90194896 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.89730449 |
| 96 | MP0009115_abnormal_fat_cell | 0.89622109 |
| 97 | MP0002398_abnormal_bone_marrow | 0.88911048 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.88599019 |
| 99 | MP0000343_altered_response_to | 0.88004826 |
| 100 | MP0002722_abnormal_immune_system | 0.87057221 |
| 101 | MP0001853_heart_inflammation | 0.86614674 |
| 102 | MP0003868_abnormal_feces_composition | 0.85273372 |
| 103 | MP0003828_pulmonary_edema | 0.84815642 |
| 104 | MP0004019_abnormal_vitamin_homeostasis | 0.84619885 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.81882772 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.81816527 |
| 107 | MP0006138_congestive_heart_failure | 0.80432871 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.80371249 |
| 109 | MP0001663_abnormal_digestive_system | 0.79612369 |
| 110 | MP0002429_abnormal_blood_cell | 0.79285545 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.76777118 |
| 112 | MP0005174_abnormal_tail_pigmentation | 0.76706355 |
| 113 | MP0005451_abnormal_body_composition | 0.75823693 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.75266992 |
| 115 | MP0005620_abnormal_muscle_contractility | 0.74996890 |
| 116 | MP0001835_abnormal_antigen_presentation | 0.73006218 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.72383984 |
| 118 | MP0005670_abnormal_white_adipose | 0.72194009 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.72103751 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.71956146 |
| 121 | MP0009642_abnormal_blood_homeostasis | 0.71196636 |
| 122 | MP0000747_muscle_weakness | 0.70218054 |
| 123 | MP0004484_altered_response_of | 0.69445277 |
| 124 | MP0003436_decreased_susceptibility_to | 0.69433342 |
| 125 | MP0004947_skin_inflammation | 0.68482526 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.68314575 |
| 127 | MP0001881_abnormal_mammary_gland | 0.68057586 |
| 128 | MP0010307_abnormal_tumor_latency | 0.67557996 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.66550108 |
| 130 | MP0003195_calcinosis | 0.66422146 |
| 131 | MP0002132_abnormal_respiratory_system | 0.66421211 |
| 132 | MP0002971_abnormal_brown_adipose | 0.66394941 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.66239921 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.66210507 |
| 135 | MP0000477_abnormal_intestine_morphology | 0.66200201 |
| 136 | MP0002106_abnormal_muscle_physiology | 0.65573083 |
| 137 | MP0005334_abnormal_fat_pad | 0.65500083 |
| 138 | MP0003953_abnormal_hormone_level | 0.64782567 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.63480217 |
| 140 | MP0002078_abnormal_glucose_homeostasis | 0.62479849 |
| 141 | MP0008872_abnormal_physiological_respon | 0.61658537 |
| 142 | MP0002249_abnormal_larynx_morphology | 0.57287104 |
| 143 | MP0003315_abnormal_perineum_morphology | 0.57237156 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.56349090 |
| 145 | MP0003329_amyloid_beta_deposits | 0.53583673 |
| 146 | MP0002970_abnormal_white_adipose | 0.48983546 |
| 147 | MP0000681_abnormal_thyroid_gland | 0.48469253 |
| 148 | MP0001849_ear_inflammation | 0.48133418 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.46194851 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.44275187 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.43161225 |
| 152 | MP0000604_amyloidosis | 0.42787322 |
| 153 | MP0002089_abnormal_postnatal_growth/wei | 0.42346162 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.39858483 |
| 155 | MP0009931_abnormal_skin_appearance | 0.38563003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 7.60472221 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.96944262 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 6.38178603 |
| 4 | Hydroxyprolinuria (HP:0003080) | 6.38178603 |
| 5 | Acanthocytosis (HP:0001927) | 6.05706452 |
| 6 | Reticulocytosis (HP:0001923) | 5.19735681 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.95361432 |
| 8 | Cholelithiasis (HP:0001081) | 4.71198276 |
| 9 | Abnormality of vitamin B metabolism (HP:0004340) | 4.56781891 |
| 10 | Hyperbilirubinemia (HP:0002904) | 4.48619440 |
| 11 | Confusion (HP:0001289) | 4.35503009 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 4.29725465 |
| 13 | Abnormal gallbladder morphology (HP:0012437) | 4.26963470 |
| 14 | Widely patent fontanelles and sutures (HP:0004492) | 4.20339466 |
| 15 | Chronic diarrhea (HP:0002028) | 4.09857833 |
| 16 | Ileus (HP:0002595) | 3.79601586 |
| 17 | Abnormality of vitamin metabolism (HP:0100508) | 3.73199902 |
| 18 | Hyperactive renin-angiotensin system (HP:0000841) | 3.69535399 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.61905576 |
| 20 | Diaphragmatic weakness (HP:0009113) | 3.57231351 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.56608685 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.54675507 |
| 23 | Glycosuria (HP:0003076) | 3.53320561 |
| 24 | Abnormality of urine glucose concentration (HP:0011016) | 3.53320561 |
| 25 | Polycythemia (HP:0001901) | 3.49208529 |
| 26 | Abnormality of reticulocytes (HP:0004312) | 3.45807051 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.32841162 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.31870291 |
| 29 | Megaloblastic anemia (HP:0001889) | 3.30276817 |
| 30 | Wide cranial sutures (HP:0010537) | 3.27634819 |
| 31 | Alkalosis (HP:0001948) | 3.26095914 |
| 32 | Myoglobinuria (HP:0002913) | 3.25928322 |
| 33 | Nausea (HP:0002018) | 3.25883617 |
| 34 | Hyperammonemia (HP:0001987) | 3.23055665 |
| 35 | Thin bony cortex (HP:0002753) | 3.21050963 |
| 36 | Abdominal distention (HP:0003270) | 3.19433873 |
| 37 | Intrahepatic cholestasis (HP:0001406) | 3.18531045 |
| 38 | Ventricular tachycardia (HP:0004756) | 3.12421906 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.10724521 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 3.08428009 |
| 41 | Abnormal gallbladder physiology (HP:0012438) | 3.06061338 |
| 42 | Cholecystitis (HP:0001082) | 3.06061338 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 3.05817705 |
| 44 | Abnormality of the gallbladder (HP:0005264) | 3.05429729 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98921584 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.98921584 |
| 47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.98132135 |
| 48 | Xanthomatosis (HP:0000991) | 2.94796020 |
| 49 | Pigmentary retinal degeneration (HP:0001146) | 2.93779301 |
| 50 | Paralysis (HP:0003470) | 2.92372047 |
| 51 | Nephrolithiasis (HP:0000787) | 2.90967842 |
| 52 | Increased purine levels (HP:0004368) | 2.89564249 |
| 53 | Hyperuricemia (HP:0002149) | 2.89564249 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.86613424 |
| 55 | Rhabdomyolysis (HP:0003201) | 2.84711084 |
| 56 | Microcytic anemia (HP:0001935) | 2.84356550 |
| 57 | Sudden death (HP:0001699) | 2.82680139 |
| 58 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.82332042 |
| 59 | Villous atrophy (HP:0011473) | 2.82332042 |
| 60 | Increased serum ferritin (HP:0003281) | 2.77411108 |
| 61 | Metabolic acidosis (HP:0001942) | 2.73071203 |
| 62 | Abnormal urine phosphate concentration (HP:0012599) | 2.71982665 |
| 63 | Palpitations (HP:0001962) | 2.70402942 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69900476 |
| 65 | Ketosis (HP:0001946) | 2.69862747 |
| 66 | Delayed epiphyseal ossification (HP:0002663) | 2.69421540 |
| 67 | Hypophosphatemia (HP:0002148) | 2.68186889 |
| 68 | Hyperparathyroidism (HP:0000843) | 2.66121912 |
| 69 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.64852770 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.63701356 |
| 71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.63193846 |
| 72 | Hypochromic anemia (HP:0001931) | 2.62662034 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.62444787 |
| 74 | Exercise-induced muscle cramps (HP:0003710) | 2.59190206 |
| 75 | Steatorrhea (HP:0002570) | 2.58000402 |
| 76 | Lipoatrophy (HP:0100578) | 2.55887967 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.54945533 |
| 78 | Hypolipoproteinemia (HP:0010981) | 2.54758483 |
| 79 | Petechiae (HP:0000967) | 2.53931825 |
| 80 | Posterior subcapsular cataract (HP:0007787) | 2.53388925 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.53227832 |
| 82 | Hyperglycinuria (HP:0003108) | 2.50914666 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.48332953 |
| 84 | Increased muscle lipid content (HP:0009058) | 2.47434452 |
| 85 | Ketoacidosis (HP:0001993) | 2.46511300 |
| 86 | Hypotension (HP:0002615) | 2.41381579 |
| 87 | Congenital sensorineural hearing impairment (HP:0008527) | 2.39180311 |
| 88 | Flat acetabular roof (HP:0003180) | 2.38964826 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.37828357 |
| 90 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34348348 |
| 91 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.34028746 |
| 92 | Gout (HP:0001997) | 2.33510164 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33029758 |
| 94 | Pustule (HP:0200039) | 2.32983469 |
| 95 | Potter facies (HP:0002009) | 2.32944763 |
| 96 | Facial shape deformation (HP:0011334) | 2.32944763 |
| 97 | Hepatic necrosis (HP:0002605) | 2.32141389 |
| 98 | Abnormal platelet function (HP:0011869) | 2.26414451 |
| 99 | Impaired platelet aggregation (HP:0003540) | 2.26414451 |
| 100 | Exercise-induced myalgia (HP:0003738) | 2.25351564 |
| 101 | Pili torti (HP:0003777) | 2.24816831 |
| 102 | Subcapsular cataract (HP:0000523) | 2.23834068 |
| 103 | Dilated cardiomyopathy (HP:0001644) | 2.22638946 |
| 104 | Hypoalphalipoproteinemia (HP:0003233) | 2.22398404 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.21365657 |
| 106 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20930649 |
| 107 | Abnormality of glycine metabolism (HP:0010895) | 2.20930649 |
| 108 | Gastrointestinal dysmotility (HP:0002579) | 2.20279299 |
| 109 | Myopathic facies (HP:0002058) | 2.18679606 |
| 110 | Hyperlipoproteinemia (HP:0010980) | 2.15698109 |
| 111 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.14381259 |
| 112 | Multiple enchondromatosis (HP:0005701) | 2.13419699 |
| 113 | Cutaneous photosensitivity (HP:0000992) | 2.13339200 |
| 114 | Vomiting (HP:0002013) | 2.11168762 |
| 115 | Abnormality of the costochondral junction (HP:0000919) | 2.10766842 |
| 116 | Subaortic stenosis (HP:0001682) | 2.10234807 |
| 117 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.10234807 |
| 118 | Prolonged partial thromboplastin time (HP:0003645) | 2.08824743 |
| 119 | Abnormal number of erythroid precursors (HP:0012131) | 2.06351880 |
| 120 | Macrocytic anemia (HP:0001972) | 2.06079139 |
| 121 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05759929 |
| 122 | Hyperphosphatemia (HP:0002905) | 2.05599390 |
| 123 | Cerebral palsy (HP:0100021) | 2.02821340 |
| 124 | Focal segmental glomerulosclerosis (HP:0000097) | 2.01188674 |
| 125 | Cerebral edema (HP:0002181) | 1.98625770 |
| 126 | Abnormality of magnesium homeostasis (HP:0004921) | 1.98396258 |
| 127 | Asymmetric septal hypertrophy (HP:0001670) | 1.98109571 |
| 128 | Enlarged epiphyses (HP:0010580) | 1.97833603 |
| 129 | Hypercholesterolemia (HP:0003124) | 1.97637958 |
| 130 | Symptomatic seizures (HP:0011145) | 1.95202098 |
| 131 | Neonatal onset (HP:0003623) | 1.94916914 |
| 132 | Urticaria (HP:0001025) | 1.94431214 |
| 133 | Abnormal hair laboratory examination (HP:0003328) | 1.94415124 |
| 134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93372851 |
| 135 | Late onset (HP:0003584) | 1.92890683 |
| 136 | Renal tubular acidosis (HP:0001947) | 1.92855127 |
| 137 | Syncope (HP:0001279) | 1.92141707 |
| 138 | Ragged-red muscle fibers (HP:0003200) | 1.91261582 |
| 139 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90307733 |
| 140 | Prolonged bleeding time (HP:0003010) | 1.89361869 |
| 141 | Insomnia (HP:0100785) | 1.87992777 |
| 142 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.87733835 |
| 143 | Epidermoid cyst (HP:0200040) | 1.87688885 |
| 144 | Lethargy (HP:0001254) | 1.87506499 |
| 145 | Hypertriglyceridemia (HP:0002155) | 1.87266700 |
| 146 | Renal tubular dysfunction (HP:0000124) | 1.85847662 |
| 147 | Atrial fibrillation (HP:0005110) | 1.85238582 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 1.84529836 |
| 149 | Protuberant abdomen (HP:0001538) | 1.83756930 |
| 150 | Proximal tubulopathy (HP:0000114) | 1.83588174 |
| 151 | Malnutrition (HP:0004395) | 1.83178897 |
| 152 | Fat malabsorption (HP:0002630) | 1.83042555 |
| 153 | Atrioventricular block (HP:0001678) | 1.82666930 |
| 154 | Irritability (HP:0000737) | 1.82355065 |
| 155 | Abnormal tarsal ossification (HP:0008369) | 1.82246600 |
| 156 | Bundle branch block (HP:0011710) | 1.80985646 |
| 157 | Esophageal neoplasm (HP:0100751) | 1.80706547 |
| 158 | Neoplasm of head and neck (HP:0012288) | 1.80706547 |
| 159 | Calf muscle hypertrophy (HP:0008981) | 1.80074738 |
| 160 | Epistaxis (HP:0000421) | 1.79526165 |
| 161 | Heart block (HP:0012722) | 1.78740913 |
| 162 | Abnormality of nucleobase metabolism (HP:0010932) | 1.78622816 |
| 163 | Multiple lipomas (HP:0001012) | 1.70000217 |
| 164 | Hyponatremia (HP:0002902) | 1.69735700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.02061392 |
| 2 | EPHA2 | 3.84989663 |
| 3 | EIF2AK1 | 3.24364155 |
| 4 | PKN2 | 3.10814922 |
| 5 | BCKDK | 3.07749214 |
| 6 | TESK2 | 2.76283643 |
| 7 | TRIB3 | 2.70905669 |
| 8 | FLT3 | 2.54506039 |
| 9 | TTN | 2.43919355 |
| 10 | ERN1 | 2.35539285 |
| 11 | STK4 | 2.35086963 |
| 12 | NME2 | 2.20293666 |
| 13 | MAP4K1 | 2.05782606 |
| 14 | EEF2K | 1.95826339 |
| 15 | LMTK2 | 1.95357708 |
| 16 | MAP3K10 | 1.83407676 |
| 17 | MYLK | 1.77841583 |
| 18 | TBK1 | 1.77618922 |
| 19 | MAPK11 | 1.70763468 |
| 20 | MAP2K3 | 1.67305442 |
| 21 | GRK6 | 1.67018122 |
| 22 | MET | 1.65158256 |
| 23 | RIPK1 | 1.63763643 |
| 24 | MAPKAPK3 | 1.60596941 |
| 25 | SMG1 | 1.60177296 |
| 26 | NEK1 | 1.56792186 |
| 27 | TYK2 | 1.56763460 |
| 28 | EPHA4 | 1.53890412 |
| 29 | MAP3K11 | 1.53677446 |
| 30 | STK10 | 1.52738515 |
| 31 | TAOK3 | 1.42100021 |
| 32 | KIT | 1.40347118 |
| 33 | EPHB2 | 1.39103314 |
| 34 | ICK | 1.38858770 |
| 35 | FGFR4 | 1.35849748 |
| 36 | KDR | 1.35727533 |
| 37 | TLK1 | 1.34044095 |
| 38 | PRPF4B | 1.31834327 |
| 39 | ZAK | 1.29885661 |
| 40 | MAP3K1 | 1.28257999 |
| 41 | IKBKE | 1.27820935 |
| 42 | PIM2 | 1.25792975 |
| 43 | STK39 | 1.25235369 |
| 44 | KSR2 | 1.24070940 |
| 45 | PIM1 | 1.23421536 |
| 46 | PDK4 | 1.22605737 |
| 47 | PDK3 | 1.22605737 |
| 48 | MAP3K2 | 1.16671093 |
| 49 | IRAK3 | 1.15973020 |
| 50 | PDPK1 | 1.13200287 |
| 51 | CDK12 | 1.11596491 |
| 52 | TIE1 | 1.11348645 |
| 53 | TGFBR2 | 1.09524866 |
| 54 | TRPM7 | 1.08224027 |
| 55 | STK24 | 1.08188189 |
| 56 | PINK1 | 1.06588626 |
| 57 | MAP3K8 | 1.05623406 |
| 58 | DDR2 | 1.04302095 |
| 59 | TESK1 | 1.03731879 |
| 60 | TAOK1 | 1.03158125 |
| 61 | RIPK4 | 1.00840666 |
| 62 | OBSCN | 1.00014619 |
| 63 | PRKAA2 | 0.98776546 |
| 64 | NEK2 | 0.98373763 |
| 65 | MAP2K2 | 0.97695434 |
| 66 | NME1 | 0.96766723 |
| 67 | WNK4 | 0.95720053 |
| 68 | PRKAA1 | 0.95115240 |
| 69 | PTK6 | 0.94647796 |
| 70 | CDK4 | 0.93305772 |
| 71 | LRRK2 | 0.91879862 |
| 72 | STK16 | 0.91149110 |
| 73 | OXSR1 | 0.90182024 |
| 74 | JAK3 | 0.88928862 |
| 75 | PRKG2 | 0.88836631 |
| 76 | JAK2 | 0.85597277 |
| 77 | DYRK3 | 0.85538846 |
| 78 | PIK3CA | 0.84036602 |
| 79 | CDC7 | 0.81998263 |
| 80 | MAP3K12 | 0.79834063 |
| 81 | BMX | 0.79329871 |
| 82 | ZAP70 | 0.79141612 |
| 83 | MAP3K7 | 0.78213574 |
| 84 | SYK | 0.78061728 |
| 85 | RPS6KB2 | 0.77699548 |
| 86 | MST1R | 0.75632098 |
| 87 | RPS6KA6 | 0.73133949 |
| 88 | RPS6KC1 | 0.72885196 |
| 89 | RPS6KL1 | 0.72885196 |
| 90 | AURKB | 0.71923525 |
| 91 | MAP3K3 | 0.71483436 |
| 92 | CDC42BPA | 0.67757555 |
| 93 | SCYL2 | 0.65070963 |
| 94 | MST4 | 0.64868973 |
| 95 | CDK6 | 0.63331278 |
| 96 | VRK1 | 0.62495358 |
| 97 | SIK1 | 0.62392718 |
| 98 | PHKG1 | 0.61578197 |
| 99 | PHKG2 | 0.61578197 |
| 100 | ERBB2 | 0.61306022 |
| 101 | RPS6KA5 | 0.60702134 |
| 102 | DYRK1B | 0.59833145 |
| 103 | DMPK | 0.56756036 |
| 104 | BTK | 0.56477036 |
| 105 | TTK | 0.55919025 |
| 106 | GRK7 | 0.55742244 |
| 107 | NEK9 | 0.55721468 |
| 108 | IKBKB | 0.55210757 |
| 109 | STK3 | 0.54887752 |
| 110 | MATK | 0.54051011 |
| 111 | ABL2 | 0.51864011 |
| 112 | EPHA3 | 0.51075306 |
| 113 | TAOK2 | 0.50178856 |
| 114 | MUSK | 0.49686421 |
| 115 | BRAF | 0.49445911 |
| 116 | FGFR3 | 0.48673449 |
| 117 | WEE1 | 0.48465677 |
| 118 | PAK4 | 0.48102253 |
| 119 | MAP2K6 | 0.47123152 |
| 120 | MAPK12 | 0.46487806 |
| 121 | CAMK2D | 0.46395279 |
| 122 | JAK1 | 0.46370385 |
| 123 | BRSK1 | 0.45491619 |
| 124 | PRKCA | 0.45053333 |
| 125 | MAPKAPK2 | 0.43993395 |
| 126 | DAPK3 | 0.42679976 |
| 127 | PRKACG | 0.40019981 |
| 128 | TNIK | 0.39925925 |
| 129 | AKT2 | 0.39099175 |
| 130 | CSF1R | 0.39030618 |
| 131 | PDK1 | 0.38253170 |
| 132 | MAP3K5 | 0.37824810 |
| 133 | RET | 0.35868068 |
| 134 | PDK2 | 0.35535250 |
| 135 | SRC | 0.34319835 |
| 136 | DAPK1 | 0.32435726 |
| 137 | PRKCZ | 0.32435329 |
| 138 | PRKCI | 0.32264896 |
| 139 | EPHB1 | 0.32239234 |
| 140 | AKT3 | 0.31661794 |
| 141 | MAP2K1 | 0.30518201 |
| 142 | PTK2 | 0.27818095 |
| 143 | NUAK1 | 0.24612020 |
| 144 | IRAK1 | 0.23429485 |
| 145 | CAMK2G | 0.20996875 |
| 146 | CDK11A | 0.20528912 |
| 147 | PBK | 0.20459752 |
| 148 | CSNK1A1 | 0.19650534 |
| 149 | VRK2 | 0.18609397 |
| 150 | PRKCD | 0.16855811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.81859885 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.13622921 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.97804542 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.89498550 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66771907 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.31097302 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20595832 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16380814 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16206851 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.16119848 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14491885 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.08981674 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.04683984 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.00838158 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.94616603 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89026293 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87761038 |
| 18 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.87235020 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77360385 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77041198 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.71438255 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69357017 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63580904 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60900877 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57838797 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56601557 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.53813617 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51193681 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48943015 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47359560 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45139710 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43666029 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.41616672 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.39091676 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36071483 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.35974042 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25632608 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23721631 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23030502 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.22570744 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18990660 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18723903 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16702762 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16107872 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13874834 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13792043 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13595935 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12554882 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12085380 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11200047 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09542634 |
| 52 | DNA replication_Homo sapiens_hsa03030 | 1.08577350 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05028119 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04098293 |
| 55 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02415608 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94983644 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94952941 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90098257 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.90090967 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88983562 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87919105 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85612546 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80807178 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80631473 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73059099 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71201384 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70540705 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70097204 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69289649 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67358116 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67216511 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66945636 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64547895 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60767793 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60454061 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58162679 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57866607 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57270949 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55862948 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.55237294 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54702188 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54601654 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.53490333 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52465764 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51796154 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51383804 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50262926 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.47963447 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.46398926 |
| 90 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44572376 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43998332 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42172201 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.41774618 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38374703 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35511431 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32910354 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31854491 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30794856 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30136647 |
| 100 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28732359 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28229909 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28023833 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.27407688 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27193925 |
| 105 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26750832 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26175809 |
| 107 | Ribosome_Homo sapiens_hsa03010 | 0.24831886 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24601182 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.24514571 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.24042393 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22821491 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.22505498 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21119718 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20724542 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20091640 |
| 116 | Mismatch repair_Homo sapiens_hsa03430 | 0.16699480 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.11463008 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08898689 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.07471803 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.06766319 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.06370996 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06317103 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.03215646 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.03131030 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0895882 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0724220 |
| 127 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0695490 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0370261 |
| 129 | Insulin secretion_Homo sapiens_hsa04911 | -0.0152668 |

